Plaque forms in the wall
Plaque develops within the artery wall, not as loose material floating in the bloodstream. That is why early plaque can exist before a person feels symptoms.
Risk Atlas · Plaque
Plaque builds inside artery walls, not in the bloodstream. That distinction matters.
Most people picture a blocked pipe. The reality is more subtle and more important. Plaque develops within the artery wall itself — through particle entry, immune-cell accumulation, lipid-core formation, and fibrous-cap development — before it ever significantly narrows the channel blood flows through. Use the slider below to move through that process, layer by layer, from a healthy artery to advanced plaque with calcific change. Then use the links to continue into inflammation, rupture, and what can follow.
Within
The artery wall
Plaque does not float in blood. It develops inside the wall — which is why it can grow undetected before it causes symptoms or narrows the channel significantly.
ApoB
The entry particle
ApoB-containing particles, including LDL, carry lipid material into the artery wall. This is why ApoB is considered a more direct measure of atherogenic particle burden than LDL-C alone.
Lp(a)
The amplifier
Lp(a) is an inherited ApoB-containing particle with additional pro-inflammatory and pro-thrombotic biology. It can amplify plaque-related risk and is not reliably lowered by diet, exercise, or standard statins.
Why plaque can be hidden
Standard cholesterol tests do not directly measure plaque. They measure markers associated with risk. Plaque can build over years without producing symptoms or appearing in routine results.
Why the fibrous cap matters
A fibrous cap separates plaque contents from flowing blood. If the cap becomes thin, inflamed, or stressed, it can rupture — exposing material that can trigger clotting. That is the next atlas module.
Why this connects to Lp(a)
Elevated Lp(a) can add to plaque-related risk, increase inflammatory activity around plaques, and contribute to plaque instability. That is why an Lp(a) result should be discussed alongside your lipid panel, ApoB, family history, and wider risk context.
Five things worth knowing about plaque
- Plaque is not cholesterol stuck to a pipe. It is a dynamic, living structure inside the artery wall — with a lipid core, immune cells, and a fibrous cover.
- ApoB is a more direct measure than LDL-C. ApoB counts the number of atherogenic particles; LDL-C measures the cholesterol they carry. A person can have normal LDL-C but high ApoB.
- Lp(a) can add to plaque risk independently. It carries ApoB-related lipid burden plus oxidised phospholipid biology. It is largely genetic and not reliably reduced by diet or standard statins.
- Plaque can narrow arteries significantly before symptoms appear. This is one reason cardiovascular events can feel sudden even when underlying disease has been building for years.
- Calcium scoring and imaging can detect plaque burden. A coronary artery calcium (CAC) scan is one way to detect and quantify plaque that standard blood tests do not show. Ask your health team whether it is relevant for you.
Plaque visualisation
Structure view separates plaque layers — endothelium, ApoB particle entry, lipid core, fibrous cap, and calcium — so the relationship between each is easier to read.
Healthy artery
Key information
Plaque: what to understand
ApoB particles matter
LDL and other ApoB-containing particles can enter the artery wall and help start plaque formation. The process is about particle exposure over time, not only a single cholesterol result.
The cap matters
Plaque includes a lipid-rich core and a fibrous cap. The cap helps explain why plaque behaviour can matter as much as plaque size.
Risk is layered
Plaque risk can be influenced by blood pressure, smoking, diabetes, kidney disease, family history, ApoB, and Lp(a). No single measurement explains the whole picture.
Prevention can start early
The best time to reduce plaque risk is before symptoms appear. Prevention usually means lowering the drivers of artery-wall injury over years, not waiting for a blockage.
Imaging and blood tests differ
Blood tests describe risk factors; imaging can sometimes show plaque or calcium directly. They answer different questions and may be used together when clinically appropriate.
Not just “blocked pipes”
Plaque is not simply a plumbing problem. It is a living artery-wall process involving lipids, immune activity, repair tissue, and sometimes calcium.
Normal cholesterol does not mean no plaque
A standard cholesterol panel may not show every important risk. Lp(a), ApoB burden, family history, blood pressure, and time all still matter.
This module is not a diagnosis or a timeline
The visual explains a process; it does not show what is happening in your arteries. Your own risk needs clinical context, measurements, and professional interpretation.
Heart risk products
Plaque is the starting point, not the whole picture.
Plaque is one piece of a wider risk context that can include ApoB discordance, elevated Lp(a), family history, blood pressure, metabolic risk, and inflammation. If you want help organising what your current checks do and do not show, Clarify is the right place to start. If you already have signals to connect, Navigate gives you a 90-day structure. If you want to build lasting preventive action, Prevent is designed for that.